Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study

ConclusionsPK profiles of 200  mg SC and IV belimumab administrations were similar to previous studies, and safety profiles were acceptable, supporting the use of the SC dose in Chinese patients with SLE.Trial registrationNCT04136145.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research